HOME >> BIOLOGY >> NEWS
BioMed Central applauds Wellcome's leadership on Open Access

Publisher BioMed Central today congratulated the Wellcome Trust on its move to require researchers receiving Wellcome funding to deposit copies of resulting research articles in an Open Access archive. The Trust announced its Open Access policy on 19 May.

"For too long, funders have stood by as the results of scientific and medical research have been handed over to traditional publishers, who have then put those research articles behind subscription barriers," said Matthew Cockerill, Director of Operations at BioMed Central. "Subscription-only access to research does not meet the needs of researchers, funders, or the general public, all of whom benefit from the widest possible access to research findings, which is what Open Access delivers."

"Following on from the National Institutes of Health's similar initiative in the USA, Wellcome's move shows that the funders who spend hundreds of millions of pounds to carry out the research in the first place are no longer prepared to see their research results remain inaccessible."

The Wellcome Trust is the UK's biggest non-governmental funder of biomedical research with an annual spend of 400 million. The recipients of Wellcome's funding produce almost 3500 scientific articles each year. With such a major funding body backing Open Access, it is now expected that other funding bodies around the world will follow suit.

Wellcome's policy specifies that articles must be made freely available within, at most, six months of initial publication, but BioMed Central called on researchers to go further and to make their research accessible immediately on publication, by choosing an Open Access journal."

"Six months is a long time in science with the rapid pace of research, quick access to the latest results is vital. So, the best way for researchers to meet the spirit of the Wellcome policy is to publish in fully Open Access journals, such as those published by BioMed Central."

Publishi
'"/>

Contact: Grace Baynes
press@biomedcentral.com
44-20-7631-9988
BioMed Central
25-May-2005


Page: 1 2

Related biology news :

1. BioMed Central announces new interdisciplinary Biofuels Journal
2. BioMed Central announces winners of first open access research awards
3. BioMed Central launches BMC Systems Biology, a new open access journal
4. Impressive new Impact Factors for BioMed Centrals open-access journals
5. BioMed Central launches Biology Direct
6. BioMed Central welcomes the new National Institutes of Health public access policy
7. BioMed Central announces publishing partnership with The Scientist magazine
8. Woods Hole Research Center scientists study impacts of industrial logging in Central Africa
9. Central and peripheral signals set the circadian liver clock
10. Announcing the launch of Open Access Central
11. EMBL-EBI and collaborators win bid to run UK PubMed Central

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: BioMed Central applauds Wellcome leadership Open Access

(Date:1/22/2015)... 2015  A man-made form of insulin delivered by nasal ... in adults with mild cognitive impairment and Alzheimer,s disease ... at Wake Forest Baptist Medical Center. The ... cognitive impairment (MCI) or mild to moderate Alzheimer,s dementia ...
(Date:1/22/2015)... Jan. 22, 2015 Research and Markets ... the "Global Wearable Technologies Market and Applications, ... Trends and Forecast 2014-2020" report to their ... smart devices that can be worn on the ...
(Date:12/22/2014)... 22, 2014 Research and Markets ( ... "The Global Watermarking and Fingerprinting Markets" ... http://photos.prnewswire.com/prnh/20130307/600769 This insight provides ... and fingerprinting markets. Watermarking aims to control and ...
Breaking Biology News(10 mins):Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2The Global Watermarking and Fingerprinting Markets 2
(Date:1/22/2015)... Geneva, Switzerland (PRWEB) January 22, 2015 ... for characterized mammalian Research Cell Banks (RCBs) used for ... generated Research Cell Banks will include Next-Generation Sequencing ... cell’s genetic architecture de-risks biologic manufacturing by ensuring the ...
(Date:1/22/2015)... 22 de enero de 2015  El Dr. Paul ... llamada a nominaciones para 2015. Este prestigioso premio reconoce ... tiene el potencial para hacer, contribuciones destacadas para la ... hasta el 15 de marzo de 2015 a través ...
(Date:1/22/2015)... Jan. 22. 2015  Varian Medical Systems (NYSE: VAR ... honored for its commitment to sustainability with inclusion on a ... the highest ranked healthcare equipment company among the Corporate Knights ... World Economic Forum at Davos, Switzerland . ...
(Date:1/22/2015)... N.J. , Jan. 22, 2015  Derma Sciences, ... regeneration company focused on advanced wound care, announces ... placental tissues, have been added to the Premier, ... increases the opportunity for the AMNIOEXCEL® and AMNIOMATRIX® ...
Breaking Biology Technology:Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4Varian Honored Among World's 100 Most Sustainable Corporations 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5
Cached News: